• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病进展的模式、危险因素及预测:一项叙述性综述

The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review.

作者信息

Collister David, Ferguson Thomas, Komenda Paul, Tangri Navdeep

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Canada; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada; Chronic Disease Innovation Center, Seven Oaks General Hospital, Winnipeg, Canada.

Department of Medicine, University of Manitoba, Winnipeg, Canada; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada; Chronic Disease Innovation Center, Seven Oaks General Hospital, Winnipeg, Canada.

出版信息

Semin Nephrol. 2016 Jul;36(4):273-82. doi: 10.1016/j.semnephrol.2016.05.004.

DOI:10.1016/j.semnephrol.2016.05.004
PMID:27475658
Abstract

Chronic kidney disease (CKD) is a global public health problem that is associated with excess morbidity, mortality, and health resource utilization. The progression of CKD is defined by a decrease in glomerular filtration rate and leads to a variety of metabolic abnormalities including acidosis, hypertension, anemia, and mineral bone disorder. Lower glomerular filtration rate also bears a strong relationship with an increased risk of cardiovascular events, end-stage renal disease, and death. Patterns of CKD progression include linear and nonlinear trajectories, but kidney function can remain stable for years in some individuals. Addressing modifiable risk factors for the progression of CKD is needed to attenuate its associated morbidity and mortality. Developing effective risk prediction models for CKD progression is critical to identify patients who are more likely to benefit from interventions and more intensive monitoring. Accurate risk-prediction algorithms permit systems to best align health care resources with risk to maximize their effects and efficiency while guiding overall decision making.

摘要

慢性肾脏病(CKD)是一个全球性的公共卫生问题,与发病率、死亡率过高以及卫生资源利用相关。CKD的进展以肾小球滤过率降低为特征,并导致包括酸中毒、高血压、贫血和矿物质骨病在内的多种代谢异常。较低的肾小球滤过率还与心血管事件、终末期肾病和死亡风险增加密切相关。CKD进展模式包括线性和非线性轨迹,但在某些个体中,肾功能可多年保持稳定。需要解决CKD进展的可改变风险因素,以减轻其相关的发病率和死亡率。开发有效的CKD进展风险预测模型对于识别更可能从干预措施和更强化监测中获益的患者至关重要。准确的风险预测算法使医疗系统能够根据风险最佳地配置卫生保健资源,以在指导总体决策的同时最大限度地提高其效果和效率。

相似文献

1
The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review.慢性肾脏病进展的模式、危险因素及预测:一项叙述性综述
Semin Nephrol. 2016 Jul;36(4):273-82. doi: 10.1016/j.semnephrol.2016.05.004.
2
Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).尿中性粒细胞明胶酶相关载脂蛋白可能有助于预测非蛋白尿 3 期和 4 期慢性肾脏病(CKD)患者的肾脏下降。
Nephrol Dial Transplant. 2013 Jun;28(6):1569-79. doi: 10.1093/ndt/gfs586. Epub 2013 Jan 16.
3
N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.N-乙酰-β-D-氨基葡萄糖苷酶和肾损伤分子-1:心力衰竭患者慢性肾脏病长期进展的新预测指标
Nephrology (Carlton). 2016 Jun;21(6):490-8. doi: 10.1111/nep.12632.
4
Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.慢性肾脏病中的肾损伤标志物1和中性粒细胞明胶酶相关脂质运载蛋白
Nephron. 2017;136(4):263-267. doi: 10.1159/000447649. Epub 2016 Oct 22.
5
Predicting Progression in CKD: Perspectives and Precautions.预测 CKD 进展:观点与预防措施。
Am J Kidney Dis. 2016 May;67(5):779-86. doi: 10.1053/j.ajkd.2015.11.007. Epub 2015 Dec 23.
6
Biomarkers of renal function, which and when?肾功能的生物标志物,哪些以及何时(检测)?
Clin Chim Acta. 2015 Jan 1;438:350-7. doi: 10.1016/j.cca.2014.08.039. Epub 2014 Sep 3.
7
Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease.慢性肾脏病患者虚弱轨迹与心血管、肾脏和死亡结局的关系。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2426-2435. doi: 10.1002/jcsm.13047. Epub 2022 Jul 19.
8
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.慢性肾脏病/终末期肾病中磷代谢紊乱:治疗考虑。
Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004.
9
Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients.老年3期和4期慢性肾病患者的肾病进展
Int Urol Nephrol. 2017 Jun;49(6):1033-1040. doi: 10.1007/s11255-017-1543-9. Epub 2017 Feb 24.
10
Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.异基因造血细胞移植后长期生存者的慢性肾脏病:患病率和危险因素。
Nephrol Dial Transplant. 2010 Jan;25(1):278-82. doi: 10.1093/ndt/gfp485. Epub 2009 Sep 17.

引用本文的文献

1
Complications of Encrusted Stents in Recurrent Nephrolithiasis: A Case Report.复发性肾结石中结痂支架的并发症:一例报告
Cureus. 2025 Apr 21;17(4):e82679. doi: 10.7759/cureus.82679. eCollection 2025 Apr.
2
Ambient PM components and prevalence of chronic kidney disease: a nationwide cross-sectional survey in China.环境 PM 成分与慢性肾脏病患病率:中国全国性横断面调查。
Environ Geochem Health. 2024 Feb 14;46(2):70. doi: 10.1007/s10653-024-01867-x.
3
Biomechanical and histomorphological analysis of the mandible in rats with chronic kidney disease.
慢性肾脏病大鼠下颌骨的生物力学和组织形态学分析。
Sci Rep. 2023 Dec 11;13(1):21886. doi: 10.1038/s41598-023-49152-8.
4
Congenital anomalies of the kidney and urinary tract: defining risk factors of disease progression and determinants of outcomes.先天性肾和尿路畸形:疾病进展的危险因素和结局的决定因素。
Pediatr Nephrol. 2023 Dec;38(12):3963-3973. doi: 10.1007/s00467-023-05899-w. Epub 2023 Mar 3.
5
The ShGlom Combines High-Throughput Drug Screening With Downstream Analyses and Reveals the Protective Role of Vitamin D3 and Calcipotriol on Podocytes.ShGlom将高通量药物筛选与下游分析相结合,揭示了维生素D3和卡泊三醇对足细胞的保护作用。
Front Cell Dev Biol. 2022 May 16;10:838086. doi: 10.3389/fcell.2022.838086. eCollection 2022.
6
The Effects of Exercise Habit on Albuminuria and Metabolic Indices in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.运动习惯对 2 型糖尿病患者蛋白尿及代谢指标的影响:一项横断面研究。
Medicina (Kaunas). 2022 Apr 23;58(5):577. doi: 10.3390/medicina58050577.
7
A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).一项研究抗性淀粉益生元对慢性肾脏病影响的随机双盲交叉试验(ReSPECKD)。
Trials. 2022 Jan 24;23(1):72. doi: 10.1186/s13063-022-06009-1.
8
Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression.与慢性肾脏病进展的快速线性和非线性模式相关的不良结局。
BMC Nephrol. 2021 Mar 6;22(1):82. doi: 10.1186/s12882-021-02282-5.
9
A Paradigm to Discover Biomarkers Associated With Chronic Kidney Disease Progression.一种发现与慢性肾脏病进展相关生物标志物的范式。
Biomark Insights. 2020 Dec 1;15:1177271920976146. doi: 10.1177/1177271920976146. eCollection 2020.
10
Serum elabela and apelin levels during different stages of chronic kidney disease.慢性肾脏病不同阶段的血清依拉贝肽和阿片肽水平。
Ren Fail. 2020 Nov;42(1):667-672. doi: 10.1080/0886022X.2020.1792926.